What oral medication is recommended for treating scabies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Treatment for Scabies

Ivermectin 200 μg/kg orally, repeated in 2 weeks, is the recommended oral medication for treating scabies 1.

Dosing and Administration

  • Standard dose: 200 μg/kg body weight
  • Timing: Two doses, 14 days apart 1
  • Critical administration detail: Must be taken with food to increase bioavailability and enhance drug penetration into the epidermis 1

The two-dose regimen is essential because ivermectin has limited ovicidal activity and cannot prevent hatching of eggs present at the time of initial treatment 1. A single dose results in only 58% treatment success compared to 98% with two doses 2, making the second dose critical to prevent treatment failure and potential resistance development.

When to Use Oral Ivermectin

Ivermectin is particularly valuable in:

  • Institutional outbreaks (nursing homes, hospitals, residential facilities) where treating entire populations is necessary 1
  • Patients who cannot tolerate or have failed topical therapy 1
  • Mass drug administration in endemic populations 3, 4

Important Contraindications and Precautions

Do not use ivermectin in:

  • Children weighing <15 kg (safety not established) 1
  • Patients with severe liver disease (safety of multiple doses unknown) 1

Use with caution in:

  • Elderly, debilitated persons (one study showed increased mortality, though not confirmed in subsequent reports) 1
  • Renal impairment (no dose adjustment needed, but monitor closely) 1

Pregnancy and lactation: Ivermectin is classified as "human data suggest low risk" and likely compatible with breastfeeding, but permethrin remains preferred due to more extensive safety data 1.

Comparative Efficacy

While topical permethrin 5% cream remains first-line therapy (more effective, safer, and less expensive than ivermectin) 1, recent meta-analysis shows oral ivermectin and topical benzyl benzoate have comparable cure rates 5. However, ivermectin demonstrates significantly better tolerability with fewer adverse events (RR: 0.27), particularly less burning/stinging (RR: 0.07) 5.

Special Situation: Crusted (Norwegian) Scabies

For severe crusted scabies, combination therapy is mandatory:

  • Oral ivermectin 200 μg/kg on days 1,2,8,9, and 15
  • PLUS topical permethrin 5% cream (full-body application daily for 7 days, then twice weekly until cure)
  • Additional ivermectin doses on days 22 and 29 may be required for severe cases 1

Never use lindane in crusted scabies due to neurotoxicity risk with heavy applications or denuded skin 1.

Follow-Up and Treatment Failure

  • Pruritus and rash may persist up to 2 weeks after successful treatment 1
  • Retreatment at 2 weeks is indicated if: live mites are observed, new lesions develop, or symptoms persist beyond 2 weeks 1
  • If initial regimen fails, switch to an alternative regimen 1

Essential Adjunctive Measures

  • Decontaminate bedding and clothing (machine wash/dry on hot cycle or dry clean) or remove from body contact for 72 hours 1
  • Treat all household and sexual contacts within the preceding month 1
  • No fumigation of living areas is necessary 1

Common Pitfall to Avoid

The most critical error is administering only a single dose of ivermectin—this is a major predictor of treatment failure (P < 0.001) and may promote resistance 2. Always ensure patients understand the necessity of the second dose at 14 days.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.